Cysteine

Cysteine

SCHEMBL5664971

NC(CS)C(=O)O.NCCS

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.80
SLC7A11 Q9UPY5 1/20 0.80
GSR P00390 2/20 0.48
CPB2 Q96IY4 2/20 0.45
ENPEP Q07075 6/20 0.44
GRIK1 P39086 2/20 0.41
GRIK2 Q13002 2/20 0.41
GRM1 Q13255 2/20 0.41
GRM2 Q14416 2/20 0.41
SLC7A5 Q01650 1/20 0.41
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
CYP1A2 P05177 1/20 0.41
GRM5 P41594 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
SLC1A3 P43003 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL5664976 1.00 PTGS1 (0.80) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL6014745 0.95 PTGS1 (0.73) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL6014744 0.95 PTGS1 (0.73) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL15418989 0.92 PTGS1 (0.84) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL15417993 0.92 PTGS1 (0.84) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL5705430 0.89 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL95110 0.89
Cysteine SCHEMBL21110883 0.89 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL1868335 0.89 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL7898895 0.89 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919178-B2 Extended tethering approach for rapid identification of ligands SUNESIS PHARMACEUTICALS, INC. (US) 2005-07-19 US claimed
EP-0547102-A4 1994-04-27 EP claimed
EP-0547102-A1 SOLUBILIZATION OF PROTEINS IN ACTIVE FORMS SOUTHERN CROSS BIOTECH PTY.LTD. (AU) 1993-06-23 EP claimed
WO-1992004382-A1 SOLUBILIZATION OF PROTEINS IN ACTIVE FORMS BUNGE (AUSTRALIA) PTY. LTD. (AU) 1992-03-19 WO claimed
EP-1513866-A4 ASSAY CONJUGATE AND USES THEREOF ABBOTT LAB (US) 2006-07-12 EP disclosed
EP-1513866-A2 ASSAY CONJUGATE AND USES THEREOF Abbott Laboratories (US) 2005-03-16 EP disclosed
EP-1373897-A1 RECOVERY OF ENZYME ACTIVITY FROM ENVELOPED VIRUSES Cavidi Tech AB (SE) 2004-01-02 EP disclosed
WO-2003106649-A2 ASSAY CONJUGATE AND USES THEREOF ABBOTT LABORATORIES (US) 2003-12-24 WO disclosed
US-20030232386-A1 Assay conjugate and uses thereof ABBOTT LABORATORIES 2003-12-18 US disclosed
WO-2002082088-A1 RECOVERY OF ENZYME ACTIVITY FROM ENVELOPED VIRUSES CAVIDI TECH AB (SE) 2002-10-17 WO disclosed
US-4510147-A FREE RADICA INHIBITION; ATHEROSCLEROSIS; RADIOLOGY; ANTITUMOR AGENTS; SENSITIZERS MATERIAL VEGYIPARI SZOVETKEZET (HU) 1985-04-09 US disclosed